Israel Englander’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Israel Englander’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,968	Closed	-$204K	–	6766
2023 Q1	$204K	Sell	4,968 -23,758	-83%	-$998K	﹤0.01%	5157
2022 Q4	$1.18M	Buy	28,726 +15,080	+111%	+$628K	﹤0.01%	4003
2022 Q3	$548K	Buy	13,646 +1,359	+11%	+$58.1K	﹤0.01%	4885
2022 Q2	$516K	Buy	12,287 +5,059	+70%	+$212K	﹤0.01%	4926
2022 Q1	$327K	Buy	+7,228	New	+$318K	﹤0.01%	5467
2021 Q3	–	Sell	-11,712	Closed	-$606K	–	7322
2021 Q2	$606K	Buy	+11,712	New	+$588K	﹤0.01%	5136
2017 Q4	–	Sell	-21,158	Closed	-$900K	–	4124
2017 Q3	$900K	Buy	+21,158	New	+$897K	﹤0.01%	2575
2015 Q4	–	Sell	-4,958	Closed	-$233K	–	3814
2015 Q3	$233K	Buy	+4,958	New	+$299K	﹤0.01%	3046
2015 Q2	–	Sell	-29,134	Closed	-$1.8M	–	3925
2015 Q1	$1.8M	Buy	29,134 +19,482	+202%	+$1.16M	﹤0.01%	2008
2014 Q4	$521K	Buy	+9,652	New	+$527K	﹤0.01%	2952

Other funds holding XPH

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Israel Englander's XPH Position: Q2 2023 in Review

Israel Englander sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2023, closing a stake of 4,968 shares — an estimated $204K sold.

Israel Englander first reported a position in XPH in Q4 2014 and held it in 10 quarters. The position peaked at $1.8M in Q1 2015. 59 funds tracked by Wall St. Rank hold XPH as of Q2 2023.

Israel Englander reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2023 after selling out during the quarter.
Israel Englander sold 4,968 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2023, an estimated $204K.
Israel Englander first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2014 and held it in 10 quarters.
Israel Englander's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.8M in Q1 2015.
59 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.